Product information and disease descriptionPlace of product in therapyApproaches to treatment
Current treatment options and standard of care
18 evidence topics · 9 sources
SL1009 (sodium dichloroacetate)
Pyruvate dehydrogenase complex deficiency
- Manufacturer
- Saol Therapeutics
- Regulatory submission
- NDA resubmitted June 2026
- Launch
- Not announced
- Last updated